416 related articles for article (PubMed ID: 1970232)
21. Continuous intragastric pH monitoring: a real progress in the assessment of antisecretory drugs.
Savarino V
Ital J Gastroenterol; 1990; 22 Suppl 2():20-3. PubMed ID: 1983412
[TBL] [Abstract][Full Text] [Related]
22. Clinical importance of the new H2-antagonists.
Walt RP
Methods Find Exp Clin Pharmacol; 1989; 11 Suppl 1():97-9. PubMed ID: 2566730
[TBL] [Abstract][Full Text] [Related]
23. Comparison of nizatidine and cimetidine as once-nightly treatment of acute duodenal ulcer. Nizatidine Multicenter Duodenal Ulcer Study Group.
Cherner JA; Cloud ML; Offen WW; Latz JE
Am J Gastroenterol; 1989 Jul; 84(7):769-74. PubMed ID: 2568086
[TBL] [Abstract][Full Text] [Related]
24. The clinical use of histamine-2 receptor antagonists.
Michocki RJ; Richardson JP
Md Med J; 1992 May; 41(5):397-400. PubMed ID: 1625532
[TBL] [Abstract][Full Text] [Related]
25. Meta-analysis of randomized clinical trials comparing lansoprazole with ranitidine or famotidine in the treatment of acute duodenal ulcer.
Poynard T; Lemaire M; Agostini H
Eur J Gastroenterol Hepatol; 1995 Jul; 7(7):661-5. PubMed ID: 8590162
[TBL] [Abstract][Full Text] [Related]
26. [Therapy and prevention of duodenal and gastric ulcer with histamine-H2-receptor antagonists].
Hentschel E
Wien Med Wochenschr; 1983; 133(4-5):104-7. PubMed ID: 6134397
[No Abstract] [Full Text] [Related]
27. Famotidine in the treatment of duodenal ulcers resistant to other histamine H2-receptor antagonists.
Chen PH; Wang TH; Wang CY; Chen CY; Cheng TC; Tsai YT; Siauw CP; Yang KC; Chen GH; Sung JL
J Int Med Res; 1989; 17 Suppl 1():25A-31A. PubMed ID: 2566541
[TBL] [Abstract][Full Text] [Related]
28. Omeprazole and H2-receptor antagonists in the acute treatment of duodenal ulcer, gastric ulcer and reflux oesophagitis: a meta-analysis.
Eriksson S; Långström G; Rikner L; Carlsson R; Naesdal J
Eur J Gastroenterol Hepatol; 1995 May; 7(5):467-75. PubMed ID: 7614110
[TBL] [Abstract][Full Text] [Related]
29. Maintenance therapy of duodenal ulcer with H2-receptor antagonists--a meta-analysis.
Palmer RH; Frank WO; Karlstadt R
Aliment Pharmacol Ther; 1990 Jun; 4(3):283-94. PubMed ID: 1983324
[TBL] [Abstract][Full Text] [Related]
30. [Comparison of famotidine and ranitidine in duodenal ulcer].
Rohner HG; Gugler R; Kimmig JM; Schönekäs H
Dtsch Med Wochenschr; 1987 Feb; 112(9):367-8. PubMed ID: 2880704
[No Abstract] [Full Text] [Related]
31. Effects of changing the type of H2-blocker in the treatment of H2-blocker-resistant ulcers: comparison of roxatidine acetate hydrochloride and other H2-blockers.
Yasutake K; Amano M; Mizokami Y; Kubota S; Fukumoto H; Imamura Y; Yokoya H; Irie K
J Int Med Res; 1998; 26(1):25-36. PubMed ID: 9513074
[TBL] [Abstract][Full Text] [Related]
32. Pharmacology of H2-receptor antagonists: an overview.
Schunack W
J Int Med Res; 1989; 17 Suppl 1():9A-16A. PubMed ID: 2566544
[TBL] [Abstract][Full Text] [Related]
33. New histamine H2-receptor antagonists.
Domschke S; Domschke W
Hepatogastroenterology; 1980 Jun; 27(3):163-8. PubMed ID: 6109690
[No Abstract] [Full Text] [Related]
34. [Histamine H2-receptor antagonists as new anti-ulcer agents].
Takemoto T
Nihon Rinsho; 1984 Jan; 42(1):103-13. PubMed ID: 6143835
[No Abstract] [Full Text] [Related]
35. Hemodynamic effects of H2-receptor antagonists.
Iberti TJ
DICP; 1990 Nov; 24(11 Suppl):S35-7. PubMed ID: 1980182
[TBL] [Abstract][Full Text] [Related]
36. [Which drug for peptic ulcer?].
Hameeteman W; Tytgat GN
Ned Tijdschr Geneeskd; 1985 Aug; 129(35):1673-6. PubMed ID: 2864643
[No Abstract] [Full Text] [Related]
37. Famotidine versus ranitidine for the short-term treatment of duodenal ulcer.
Simon B; Dammann HG; Jakob G; Miederer SE; Müller P; Ottenjann R; Paul F; Scholten T; Schütz E; Seifert E
Digestion; 1985; 32 Suppl 1():32-7. PubMed ID: 2866134
[TBL] [Abstract][Full Text] [Related]
38. Review of an extensive worldwide study of a new H2-receptor antagonist, famotidine, as compared to ranitidine in the treatment of acute duodenal ulcer.
Bianchi Porro G; Dicenta C; Cook T; Humphries TJ
J Clin Gastroenterol; 1987; 9 Suppl 2():14-8. PubMed ID: 2887613
[TBL] [Abstract][Full Text] [Related]
39. [Clinical importance of antagonists of histamine H2 receptors in gastroenterology].
Carella G
Clin Ter; 1984 Mar; 108(6):525-9. PubMed ID: 6144411
[No Abstract] [Full Text] [Related]
40. H2-receptor antagonists: development and application.
Feldman S
N Engl Reg Allergy Proc; 1986; 7(4):362-6. PubMed ID: 2886903
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]